Abstract: Disclosed herein are polyurethane foams which can be used for reducing or preventing the corrosion of polymeric materials, which can be produced by mixing components (a) at least one polyisocyanate, (b) at least one compound having at least two groups reactive toward isocyanates, (c) optionally chain extender and/or crosslinking agent, (d) blowing agent, (e) catalyst, (f) optionally auxiliaries and additives, and (g) at least one anhydride to give a reaction mixture, and curing said reaction mixture to give the polyurethane foams, where the anhydride is added in an amount of 0.05-5 wt %, based on the weight of component (a). Also disclosed herein are a method of reducing or preventing the corrosion of polymeric materials by using such polyurethane foams and a method of using the polyurethane foams in certain applications, for example, in automotive interiors.

Abstract: Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Abstract: A power line communication-based pairing method and device for an air conditioner, and a storage medium are provided. Based on a pairing request instruction, A CCO module on an indoor side selects an STA module to be paired, in a power line network, for use as a pairing object. The CCO module sends pairing request information to the power line network. The STA module receives the pairing request information. If the STA module determines that identification information thereof exists in the pairing request information, the STA module establishes a pairing relationship with the CCO module. The STA module sends pairing feedback information to the power line network. The CCO module receives the pairing feedback information. If the CCO module determines that the identification information thereof exists in the pairing feedback information, the CCO module determines that the pairing is successful and establishes a pairing relationship with the STA module.

Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

Abstract: A laser transmit module includes a capacitor, a laser transmitter, and a field effect transistor. The capacitor is configured to supply power to the laser transmitter. The field effect transistor is configured to control the laser transmitter to be turned on. The capacitor, the laser transmitter, and the field effect transistor are interconnected through conductive pins to form a laser transmission loop. Loop inductance generated by the laser transmission loop affects a pulse peak value of a laser pulse transmitted by the laser transmitter, thereby affecting a detection distance of the laser pulse. Therefore, the laser transmission loop is formed through a direct connection between the conductive pins of the capacitor, the laser transmitter, and the field effect transistor, to reduce distances between the components and reduce an area of the formed laser transmission loop, so as to increase the detection distance of the laser transmit module.

Abstract: The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

Abstract: The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

Abstract: Disclosed are compounds having the formula (I) wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.

Abstract: Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Abstract: In some examples, a service provider may manage inventories of items by offering money advances to make inventory orders on behalf of a merchant. The service provider may determine a risk associated with advancing money to the merchant based on sales of items made by the merchant. The service provider may provide a money advance to the merchant when the risk associated with advancing money is within a threshold level. The money advance may be used to order inventory from a supplier. This may assist the merchant in managing inventory.

Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

Abstract: At least one device can be classified based on user activity. At least one telemetry variable with respect to time may be received for the at least one device. The at least one telemetry variable with respect to time may be used to determine an activity model for the at least one device. Based on the activity model, a probability of the at least one device belonging to a profile or to a type of user may be determined. Based on the type of user of the at least one device, a setting associated with the at least one device may be changed.

Abstract: A travel recommendation method, an electronic device, and a storage medium are provided, which are related to artificial intelligence, and particularly relates to fields of depth learning, map navigation and the like. The specific implementation scheme includes: obtaining a travel recommendation model according to constraint conditions and prediction conditions, wherein the constraint conditions are used for characterizing travel fairness for different types of users travelling at different moments and in different regions, and the prediction conditions are used for characterizing at least two travel modes selected by the different types of users; and obtaining travel recommendation information according to a travel target and the travel recommendation model.

Abstract: The present application relates to novel substituted imidazo[4,5-c]cinnolin-2-one compounds and pharmaceutically acceptable salts thereof, which selectively modulate ataxia telangiectasia mutated (“ATM”) kinase. The present application also relates to pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and to the use of the compounds and salts thereof in the treatment of ATM-associated diseases or conditions, including cancers.

Abstract: The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

Abstract: Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Abstract: This invention relates to, among other items, benzoxaborole compounds and their use for treating bacterial infections.

Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.